Composition
- Active ingredients
- ACRIVASTINE 8MG; PSEUDOEPHEDRINE HYDROCHLORIDE 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA019806.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Semprex-D
- Active substance
- acrivastine
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Endo Operations
- Status
- Discontinued
- FDA approval
- 25 Mar 1994
- Application
- NDA019806-001